Fairvalue-Calculator Fairvalue-Calculator
EN DE

Skylight Health Group (SLHGF) Fair Value & Analysis

Healthcare · US · Market cap $4.0K

Price$0.0001
Fair Value$0.0001
Upside+0.0%
Quality87/100
Evidence: Low Range $0.0001 – $0.0001

Fair value as of: Jun 26, 2026

Analysis

Skylight Health Group (SLHGF) currently trades at $0.0001, while our model-based Fair Value estimate is $0.0001 — implying the stock looks roughly 0.0% undervalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

About the company

Skylight Health Group Inc. operates as a healthcare services and technology company in the United States. The company operates the US multi-state primary care health network, which provides a range of services from primary and urgent care, sub-specialty, allied health and wellness, and laboratory/diagnostic testing. It also provides healthcare services for older and disabled patients. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Skylight Health Group (SLHGF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0001 versus a price of $0.0001 — about +0% (undervalued). Model-based estimate, not financial advice.
What is the fair value of SLHGF?
Our 21-model fair value for Skylight Health Group is $0.0001 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0001.
What is the quality score of SLHGF?
Skylight Health Group has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.